178 related articles for article (PubMed ID: 17699331)
21. Biological therapies: new treatment options for ANCA-associated vasculitis?
Aries PM; Lamprecht P; Gross WL
Expert Opin Biol Ther; 2007 Apr; 7(4):521-33. PubMed ID: 17373903
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome.
Sinico RA; Di Toma L; Maggiore U; Bottero P; Radice A; Tosoni C; Grasselli C; Pavone L; Gregorini G; Monti S; Frassi M; Vecchio F; Corace C; Venegoni E; Buzio C
Arthritis Rheum; 2005 Sep; 52(9):2926-35. PubMed ID: 16142760
[TBL] [Abstract][Full Text] [Related]
23. ANCA Glomerulonephritis and Vasculitis.
Jennette JC; Nachman PH
Clin J Am Soc Nephrol; 2017 Oct; 12(10):1680-1691. PubMed ID: 28842398
[TBL] [Abstract][Full Text] [Related]
24. [Treatment of ANCA-associated vascularitides].
Guillevin L; Pagnoux C
Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
[TBL] [Abstract][Full Text] [Related]
25. ANCA glomerulonephritis and vasculitis: a Chapel Hill perspective.
Falk RJ; Nachman PH; Hogan SL; Jennette JC
Semin Nephrol; 2000 May; 20(3):233-43. PubMed ID: 10855933
[TBL] [Abstract][Full Text] [Related]
26. Predictive value of antineutrophil cytoplasmic antibodies in small-vessel vasculitis.
Lurati-Ruiz F; Spertini F
J Rheumatol; 2005 Nov; 32(11):2167-72. PubMed ID: 16265696
[TBL] [Abstract][Full Text] [Related]
27. Primary systemic vasculitis.
Day C; Savage C
Minerva Med; 2001 Oct; 92(5):349-63. PubMed ID: 11675579
[TBL] [Abstract][Full Text] [Related]
28. [Antineutrophil cytoplasmic antibody(ANCA)].
Yoshida M
Rinsho Byori; 2003 Jul; 51(7):644-8. PubMed ID: 12924248
[TBL] [Abstract][Full Text] [Related]
29. Crescentic glomerulonephritis associated with myeloperoxidase-antineutrophil-cytoplasmic antibodies: first report on the efficacy of primary anti-TNF-alpha treatment.
Zaenker M; Arbach O; Helmchen U; Glorius P; Ludewig S; Braasch E
Int J Tissue React; 2004; 26(3-4):85-92. PubMed ID: 15648440
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic effect of anti-TNF-alpha antibodies in an experimental model of anti-neutrophil cytoplasm antibody-associated systemic vasculitis.
Little MA; Bhangal G; Smyth CL; Nakada MT; Cook HT; Nourshargh S; Pusey CD
J Am Soc Nephrol; 2006 Jan; 17(1):160-9. PubMed ID: 16306166
[TBL] [Abstract][Full Text] [Related]
31. Immunosuppressive therapy and clinical evolution in forty-nine patients with antineutrophil cytoplasmic antibody-associated glomerulonephritis.
Kokolina E; Alexopoulos E; Dimitriadis C; Vainas A; Giamalis P; Papagianni A; Ekonomidou D; Memmos D
Ann N Y Acad Sci; 2005 Jun; 1051():597-605. PubMed ID: 16127000
[TBL] [Abstract][Full Text] [Related]
32. [Anti-neutrophil cytoplasmic antibodies (ANCA): major progress in the diagnosis of vasculitis].
Goldman M; Servais C; Lambermont M; Tielemans C; Lambrechts A; Mascart-Lemone F; Dupont E
Rev Med Brux; 1992 Nov; 13(9):333-6. PubMed ID: 1361072
[TBL] [Abstract][Full Text] [Related]
33. [Review article: Antineutrophil cytoplasmic antibody in small vessel vasculitis].
Nakano H; Ozaki S
Rinsho Byori; 2010 May; 58(5):480-9. PubMed ID: 20560457
[TBL] [Abstract][Full Text] [Related]
34. Drug insight: anti-tumor necrosis factor therapies for the vasculitic diseases.
Langford CA
Nat Clin Pract Rheumatol; 2008 Jul; 4(7):364-70. PubMed ID: 18506159
[TBL] [Abstract][Full Text] [Related]
35. Plasma exchange in the treatment of Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and renal limited vasculitis.
Casian A; Jayne D
Curr Opin Rheumatol; 2011 Jan; 23(1):12-7. PubMed ID: 21124082
[TBL] [Abstract][Full Text] [Related]
36. The utility of tumour necrosis factor blockade in orphan diseases.
Keystone EC
Ann Rheum Dis; 2004 Nov; 63 Suppl 2(Suppl 2):ii79-ii83. PubMed ID: 15479879
[TBL] [Abstract][Full Text] [Related]
37. [ANCA-associated vasculitis].
Sinico RA; Sabadini E; Boeri R; Radice A
G Ital Nefrol; 2002; 19(2):125-36. PubMed ID: 12195410
[TBL] [Abstract][Full Text] [Related]
38. [Are anti-TNFAb indicated in systemic necrotizing vasculitides?].
Guillevin L
Rev Med Interne; 2005 Oct; 26(10):769-70. PubMed ID: 16039017
[No Abstract] [Full Text] [Related]
39. Pauci-immune necrotizing glomerulonephritis.
Rutgers A; Sanders JS; Stegeman CA; Kallenberg CG
Rheum Dis Clin North Am; 2010 Aug; 36(3):559-72. PubMed ID: 20688250
[TBL] [Abstract][Full Text] [Related]
40. Anti-neutrophil cytoplasmic antibodies: a new class of autoantibodies in glomerulonephritis, vasculitis and other inflammatory disorders.
Tervaert JW; Stegeman CA; Brouwer E; Mulder AH; Limburg PC; Kallenberg CG
Neth J Med; 1994 Dec; 45(6):262-72. PubMed ID: 7838242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
